Journal of Andrology Cross-Journal Searching
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Donnell, L.
Right arrow Articles by McLachlan, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Donnell, L.
Right arrow Articles by McLachlan, R. I.

Journal of Andrology, Vol 20, Issue 1 109-117, Copyright © 1999 by The American Society of Andrology


JOURNAL ARTICLE

Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5alpha-reductase inhibitor

L. O'Donnell, K. Pratis, P. G. Stanton, D. M. Robertson and R. I. McLachlan
Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia.

Germ cell development (spermiogenesis in particular) in the adult rat is known to be testosterone dependent. Recently we proposed a role for the 5alpha reduction of testosterone to dihydrotestosterone (DHT) in the short-term restoration of round spermatid maturation when testicular testosterone levels are experimentally lowered. The current study aimed to further characterize the involvement of 5alpha-reductase in the restoration of spermatogenesis by investigating the short- and long-term restoration of specific germ cell populations by testosterone in the presence or absence of a 5alpha-reductase inhibitor (L685,273). Spermatogenesis in adult rats was suppressed for 8 weeks using 3-cm testosterone and 0.4-cm estradiol silastic implants (testosterone-estradiol [TE] treatment); spermatogenesis was then restored by administration of increasing doses of testosterone with or without a competitive 5alpha-reductase inhibitor or with the androgen receptor antagonist flutamide. Animals were then killed after either 4 days or 6 weeks of treatment so that we could study the short- and long-term restorations of spermatogenesis. Stereological analysis showed that germ cell development between late pachytene spermatocytes to round spermatids in stage VII during either short- or long-term restoration was not affected by 5alpha-reductase inhibition, but it was affected by flutamide. The conversion of round spermatids between stages VII and VIII was restored by testosterone treatment, but this restoration was prevented by flutamide. Both the short- and long-term restorations of this midspermiogenic event were significantly decreased when 5alpha-reductase was inhibited. After long-term restoration of spermatogenesis, elongated spermatids were restored to 42% of control but were significantly suppressed to 20% of control by coadministration of the 5alpha-reductase inhibitor because of a reduction in the number of round spermatids progressing between stages VII and VIII. The results demonstrate that the 5alpha-reduction of testosterone is particularly important for progression through midspermiogenesis, because this phase of germ cell development is more sensitive to withdrawal of androgens. We suggest that testicular 5alpha-reductase activity is important for the restoration or maintenance of low levels of sperm production in a hormonally based contraceptive setting.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. T. Page, J. K. Amory, and W. J. Bremner
Advances in Male Contraception
Endocr. Rev., June 1, 2008; 29(4): 465 - 493.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. J Meachem, S. Schlatt, S. M Ruwanpura, and P. G Stanton
The effect of testosterone, dihydrotestosterone and oestradiol on the re-initiation of spermatogenesis in the adult photoinhibited Djungarian hamster
J. Endocrinol., March 1, 2007; 192(3): 553 - 561.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. L. Matthiesson and R. I. McLachlan
Male hormonal contraception: concept proven, product in sight?
Hum. Reprod. Update, July 1, 2006; 12(4): 463 - 482.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P Sluka, L O'Donnell, J R Bartles, and P G Stanton
FSH regulates the formation of adherens junctions and ectoplasmic specialisations between rat Sertoli cells in vitro and in vivo.
J. Endocrinol., May 1, 2006; 189(2): 381 - 395.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. L. Matthiesson, P. G. Stanton, L. O'Donnell, S. J. Meachem, J. K. Amory, R. Berger, W. J. Bremner, and R. I. McLachlan
Effects of Testosterone and Levonorgestrel Combined with a 5{alpha}-Reductase Inhibitor or Gonadotropin-Releasing Hormone Antagonist on Spermatogenesis and Intratesticular Steroid Levels in Normal Men
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5647 - 5655.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. J Meachem, D. M Robertson, N. G Wreford, R. I McLachlan, and P. G Stanton
Oestrogen does not affect the restoration of spermatogenesis in the gonadotrophin-releasing hormone-immunised adult rat
J. Endocrinol., June 1, 2005; 185(3): 529 - 538.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. L. Matthiesson, J. K. Amory, R. Berger, A. Ugoni, R. I. McLachlan, and W. J. Bremner
Novel Male Hormonal Contraceptive Combinations: The Hormonal and Spermatogenic Effects of Testosterone and Levonorgestrel Combined with a 5{alpha}-Reductase Inhibitor or Gonadotropin-Releasing Hormone Antagonist
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Vigier, M Weiss, M H Perrard, M Godet, and P Durand
The effects of FSH and of testosterone on the completion of meiosis and the very early steps of spermiogenesis of the rat: an in vitro study
J. Mol. Endocrinol., December 1, 2004; 33(3): 729 - 742.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. S. Cupp, M. Uzumcu, H. Suzuki, K. Dirks, B. Phillips, and M. K. Skinner
Effect of Transient Embryonic In Vivo Exposure to the Endocrine Disruptor Methoxychlor on Embryonic and Postnatal Testis Development
J Androl, September 1, 2003; 24(5): 736 - 745.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Killian, K. Pratis, R. J. Clifton, P. G. Stanton, D. M. Robertson, and L. O'Donnell
5{alpha}-Reductase Isoenzymes 1 and 2 in the Rat Testis During Postnatal Development
Biol Reprod, May 1, 2003; 68(5): 1711 - 1718.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. A. Anderson and D. T. Baird
Male Contraception
Endocr. Rev., December 1, 2002; 23(6): 735 - 762.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. I. McLachlan, L. O'Donnell, P. G. Stanton, G. Balourdos, M. Frydenberg, D. M. de Kretser, and D. M. Robertson
Effects of Testosterone Plus Medroxyprogesterone Acetate on Semen Quality, Reproductive Hormones, and Germ Cell Populations in Normal Young Men
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 546 - 556.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
R.I. McLachlan, L. O'Donnell, S.J. Meachem, P.G. Stanton, D.M. de Kretser, K. Pratis, and D.M. Robertson
Identification of Specific Sites of Hormonal Regulation in Spermatogenesis in Rats, Monkeys, and Man
Recent Prog. Horm. Res., January 1, 2002; 57(1): 149 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Yu and D. J. Handelsman
Pharmacogenetic Polymorphisms of the AR and Metabolism and Susceptibility to Hormone- Induced Azoospermia
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4406 - 4411.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. O. Hardy, R.-S. Ge, J. F. Catterall, Y.-t. Hou, T. M. Penning, and M. P. Hardy
Identification of the Oxidative 3{alpha}-Hydroxysteroid Dehydrogenase Activity of Rat Leydig Cells as Type II Retinol Dehydrogenase
Endocrinology, May 1, 2000; 141(5): 1608 - 1617.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The American Society of Andrology.